Fox Chase Research at the ASCO Annual Meeting

News & Publications

Press Releases, Social Media, Video
Press Kit Resources
Read more »

News Releases

Patient interest, willingness to pay out of pocket costs for tumor genetic profiling assessed by Fox Chase researchers
(May 21, 2015)

Although recent survey participants expressed an interest in comprehensive tumor genetic profiling, participants with lower income, less education, and non-private insurance were less likely to pursue it if out-of-pocket costs were involved, according to recent study findings.

Next Generation Sequencing-Based Tumor Genomic Profiling Aids in Detecting Hereditary Variants in Cancer Risk Genes
(May 20, 2015)

Cancer patients are increasingly having their tumors tested using comprehensive genomic profiling (CGP) to identify genetic mutations that can be targeted by precision therapies.

African Americans Prone To Display Negative Perceptions of Cancer-Related Clinical Trials
(May 19, 2015)

Researchers from Fox Chase Cancer Center and Temple University recently explored the differences between African-Americans who did and did not participate in a clinical trial and found significant discrepancies in perceptions and beliefs between the two groups.

New Targeted Treatment IMMU-130 Shows Promise in Patients with Metastatic Colon Cancer
(May 18, 2015)

Antibody-drug conjugates are a promising option, due to the fact that they can deliver chemotherapy directly into a targeted cell and destroy tumor cells while keeping healthy ones intact.

 

Press Releases 2015

Find a Clinical Trial

Find a Clinical Trial

Benefit from new cancer treatments
Read more »

Fox Chase Research Faculty - Alphabetical Listing

Faculty Directory

Our research faculty
Read more »

Each year, Fox Chase Cancer Center researchers present their findings at the annual meeting of the American Society of Clinical Oncology (ASCO). 

ASCO 2015

See what Fox Chase Cancer Center researchers are presenting at the 51st annual meeting of the American Society of Clinical Oncology (ASCO).

Patient interest, willingness to pay out of pocket costs for tumor genetic profiling assessed by Fox Chase researchers
(May 21, 2015)
Next Generation Sequencing-Based Tumor Genomic Profiling Aids in Detecting Hereditary Variants in Cancer Risk Genes
(May 20, 2015)
African Americans Prone To Display Negative Perceptions of Cancer-Related Clinical Trials
(May 19, 2015)
New Targeted Treatment IMMU-130 Shows Promise in Patients with Metastatic Colon Cancer
(May 18, 2015)


ASCO 2014

See what Fox Chase Cancer Center researchers are presenting at the 50th annual meeting of the American Society of Clinical Oncology (ASCO).

 

 

 

 

 


Fox Chase at ASCO 2013

Head and Neck Cancer Patients Fare Better with HPV
(May 29, 2013)
Fox Chase Researchers Uncover Novel Mechanism of Promising Drug Treatment for Colon Cancer
(May 29, 2013)
Many Solid Tumors Carry Genetic Changes Targeted by Existing Compounds
(May 29, 2013)
Fox Chase Study Shows that for Patients with Metastatic Pancreatic Cancer, Both Treatment and Survival Decrease with Advanced Age
(May 29, 2013)
New Technique Alleviates Painful Bone Metastases
(May 29, 2013)
Fox Chase Researchers Narrow the Search for Biomarkers of Drug Resistance in Head and Neck Cancer Patients
(May 29, 2013)
Researchers Investigate a Less Toxic Radiation Treatment for HPV-Positive Oropharynx Cancer
(May 29, 2013)
New Therapy is Tolerable in Lung Cancer
(May 29, 2013)

 .

Forward
Forward
broadening the conversation
about cancer

Online at 
forward.foxchase.org »

NOW
FOX CHASE NOW

Online at 
foxchase.org/ foxchasenow/ »


More Fox Chase Cancer Center Press Releases

News Contacts

 

Jeremy Moore
Senior Director, Communications
Jeremy.Moore@fccc.edu